Advances in Nucleic Acid Drugs and Gene Therapies based on Animal Models of Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a severe X-linked recessive genetic disorder caused by mutations in the DMD gene, making it one of the most common forms of hereditary muscular dystrophy. The DMD gene, which encodes dystrophin, is the largest known gene in the human genome. Mutations in the DMD...
Saved in:
| Main Authors: | LIU Siyu, LAI Yuezhao, GUO Wenting, CHEN Xuejin |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Laboratory Animal and Comparative Medicine
2024-12-01
|
| Series: | Shiyan dongwu yu bijiao yixue |
| Subjects: | |
| Online Access: | https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2024.168 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies
by: V. M. Suslov, et al.
Published: (2024-11-01) -
Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
by: S. B. Artemyeva, et al.
Published: (2024-01-01) -
Golodirsen restores DMD transcript imbalance in Duchenne Muscular Dystrophy patient muscle cells
by: Rachele Rossi, et al.
Published: (2024-11-01) -
Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01) -
Understanding Duchenne muscular dystrophy-associated brain pathology
by: Minou A. T. Verhaeg, et al.
Published: (2025-07-01)